Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Conversion to Open Surgery × Gastrointestinal × 90 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colonic Neoplasms 1

Interventions

Oxaliplatin 122 Fluorouracil 119 Bevacizumab 95 pembrolizumab 92 Leucovorin 89 Specimen Handling 84 Gemcitabine 81 Capecitabine 76 Magnetic Resonance Spectroscopy 69 Irinotecan 66 Cisplatin 54 Nivolumab 53 Cetuximab 52 Biopsy 51 durvalumab 49 130-nm albumin-bound paclitaxel 41 atezolizumab 37 Drug Therapy 37 Paclitaxel 35 Radiotherapy 29 Folfox protocol 29 Taxes 28 Carboplatin 27 Albumin-Bound Paclitaxel 27 regorafenib 26 dehydroftorafur 25 Cyclophosphamide 23 tislelizumab 22 Trastuzumab 22 fludarabine 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07314996 2026-01-02

LOVO

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase NA Not yet recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡